Aster Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Aster Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-354	Closed	-$86.2K	–	869
2026 Q1	$86.2K	Buy	+354	New	+$102K	0.03%	355
2025 Q4	–	Sell	-18	Closed	-$5.05K	–	1115
2025 Q3	$5.05K	Sell	18 -279	-94%	-$75.9K	﹤0.01%	806
2025 Q2	$71.7K	Sell	297 -2,145	-88%	-$507K	0.02%	559
2025 Q1	$648K	Buy	+2,442	New	+$735K	0.12%	236
2024 Q4	–	Sell	-106	Closed	-$35.5K	–	1141
2024 Q3	$35.5K	Buy	+106	New	+$33.7K	0.01%	570

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Aster Capital Management's BIO Position: Q2 2026 in Review

Aster Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 354 shares — an estimated $86.2K sold.

Aster Capital Management first reported a position in BIO in Q3 2024 and held it in 5 quarters. The position peaked at $648K in Q1 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Aster Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
Aster Capital Management sold 354 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $86.2K.
Aster Capital Management first reported a position in Bio-Rad Laboratories Class A in Q3 2024 and held it in 5 quarters.
Aster Capital Management's Bio-Rad Laboratories Class A position peaked at $648K in Q1 2025.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.